【结 构 式】 |
【分子编号】27766 【品名】phenyl(3-pyridinyl)methanone 【CA登记号】5424-19-1 |
【 分 子 式 】C12H9NO 【 分 子 量 】183.2096 【元素组成】C 78.67% H 4.95% N 7.65% O 8.73% |
合成路线1
该中间体在本合成路线中的序号:(IV)The condensation of 6-bromohexanoic acid (I) with triphenylphosphine in refluxing acetonitrile gives the corresponding phosphonium salt (III), which is submitted to a Wittig condensation with phenyl 3-pyridyl ketone (IV) by means of NaH in DMSO, yielding a mixture of the title product and its (Z)-isomer (V). This mixture of isomers is separated by fractional crystallization or HPLC and the isomeric compound (V) is treated with refluxing aqueous 25% HBr to perform its isomerization to CV-415.
【1】 Kato, K.; et al.; Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of omega-pyridilalkenoic acids. J Med Chem 1985, 28, 3, 287-294. |
【2】 Terao, S.; et al. (Takeda Chemical Industries, Ltd.); Substituted vinylcarboxylic acid derivative and its preparation. JP 58219162 . |
【3】 Castaner, J.; Serradell, M.N.; CV-4151. Drugs Fut 1986, 11, 3, 183. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27765 | 6-bromohexanoic acid | 4224-70-8 | C6H11BrO2 | 详情 | 详情 |
(III) | 18264 | (5-Carboxypentyl)triphenylphosphonium bromide; (5-carboxypentyl)(triphenyl)phosphonium bromide | 50889-29-7 | C24H26BrO2P | 详情 | 详情 |
(IV) | 27766 | phenyl(3-pyridinyl)methanone | 5424-19-1 | C12H9NO | 详情 | 详情 |
(V) | 27767 | (Z)-7-phenyl-7-(3-pyridinyl)-6-heptenoic acid | C18H19NO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Alkylation of 3-benzoylpyridine (I) with methyl 2-bromopropionate (II) in refluxing acetone afforded pyridinium salt (III). The subsequent regiospecific copper-catalyzed condensation of (III) with cyclohexylmagesium chloride (IV) yielded dihydropyridine (V). Finally, ammonolysis of the methyl acetate ester of (V) provided the title amide.
【1】 Agudoawu, S.A.; et al.; Synthesis and analgesic activity of 2-methyl-2-[1-(3-benzoyl-4-substituted-1,4-dihydropyridyl)]acetic acid methyl esters, acetic acids, and acetamides. Arch Pharm 1999, 332, 6, 213. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27766 | phenyl(3-pyridinyl)methanone | 5424-19-1 | C12H9NO | 详情 | 详情 |
(II) | 34941 | methyl 2-bromopropanoate; 2-bromopropionic acid methyl ester | 5445-17-0 | C4H7BrO2 | 详情 | 详情 |
(III) | 34942 | 3-benzoyl-1-(2-methoxy-1-methyl-2-oxoethyl)pyridinium bromide | C16H16BrNO3 | 详情 | 详情 | |
(IV) | 31866 | chloro(cyclohexyl)magnesium | C6H11ClMg | 详情 | 详情 | |
(V) | 34943 | methyl 2-[3-benzoyl-4-cyclohexyl-1(4H)-pyridinyl]propanoate | C22H27NO3 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)Nitration of 3-benzoylpyridine (I) with KNO3 in sulfuric acid yielded the meta-nitrobenzoyl derivative (II). Wadsworth-Emmons reaction of ketone (II) with triethyl phosphonoacetate produced the unsaturated ester (IIIa-b) as a mixture of geometric isomers. Nitro group reduction in (IIIa-b) employing Fe and HCl gave aniline (IVa-b), which was condensed with 4-methoxybenzenesulfonyl chloride (V) to afford sulfonamide (VIa-b). After conversion of the pyridine ring of (VIa-b) to the corresponding N-oxide (VIIa-b) with m-chloroperbenzoic acid, the sulfonamide N atom of (VIIa-b) was alkylated with isopropyl iodide and K2CO3 to produce (VIIIa-b). Reduction of the N-oxide of (VIIIa-b) by means of Fe and HOAc, followed by basic hydrolysis of the ethyl ester, furnished acid (IXa-b). This was then coupled with O-t-butyldimethylsilyl hydroxylamine to provide, after separation of the Z/E isomeric mixture, the desired hydroxamic acid.
【1】 Hirata, T.; et al.; Discovery of potent, highly selective, and orally active propenohydroxamate TNF-alpha converting enzyme (TACE) inhibitors. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 262. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IIIa) | 51303 | ethyl (E)-3-(3-nitrophenyl)-3-(3-pyridinyl)-2-propenoate | C16H14N2O4 | 详情 | 详情 | |
(IIIb) | 51304 | ethyl (Z)-3-(3-nitrophenyl)-3-(3-pyridinyl)-2-propenoate | C16H14N2O4 | 详情 | 详情 | |
(IVa) | 51305 | ethyl (E)-3-(3-aminophenyl)-3-(3-pyridinyl)-2-propenoate | C16H16N2O2 | 详情 | 详情 | |
(IVb) | 51306 | ethyl (Z)-3-(3-aminophenyl)-3-(3-pyridinyl)-2-propenoate | C16H16N2O2 | 详情 | 详情 | |
(VIa) | 51307 | ethyl (E)-3-(3-[[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-(3-pyridinyl)-2-propenoate | C23H22N2O5S | 详情 | 详情 | |
(VIb) | 51308 | ethyl (Z)-3-(3-[[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-(3-pyridinyl)-2-propenoate | C23H22N2O5S | 详情 | 详情 | |
(VIIa) | 51309 | 3-[(E)-3-ethoxy-1-(3-[[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-oxo-1-propenyl]-1-pyridiniumolate | C23H22N2O6S | 详情 | 详情 | |
(VIIb) | 51310 | 3-[(Z)-3-ethoxy-1-(3-[[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-oxo-1-propenyl]-1-pyridiniumolate | C23H22N2O6S | 详情 | 详情 | |
(VIIIa) | 51311 | 3-[(Z)-3-ethoxy-1-(3-[isopropyl[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-oxo-1-propenyl]-1-pyridiniumolate | C26H28N2O6S | 详情 | 详情 | |
(VIIIb) | 51312 | 3-[(E)-3-ethoxy-1-(3-[isopropyl[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-oxo-1-propenyl]-1-pyridiniumolate | C26H28N2O6S | 详情 | 详情 | |
(IXa) | 51313 | (E)-3-(3-[isopropyl[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-(3-pyridinyl)-2-propenoic acid | C24H24N2O5S | 详情 | 详情 | |
(IXb) | 51314 | (Z)-3-(3-[isopropyl[(4-methoxyphenyl)sulfonyl]amino]phenyl)-3-(3-pyridinyl)-2-propenoic acid | C24H24N2O5S | 详情 | 详情 | |
(I) | 27766 | phenyl(3-pyridinyl)methanone | 5424-19-1 | C12H9NO | 详情 | 详情 |
(II) | 51302 | (3-nitrophenyl)(3-pyridinyl)methanone | C12H8N2O3 | 详情 | 详情 | |
(V) | 15719 | 4-methoxybenzenesulfonyl chloride | 98-68-0 | C7H7ClO3S | 详情 | 详情 |